Rigel Pharmaceuticals, Inc. (RIGL)
USD 17.07
(-7.48%)
USD 17.07
(-7.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.74 Million | -73.75 Million | 5.87 Million | -52.18 Million | -41.51 Million | -58.82 Million |
| Net Income | -25.09 Million | -58.57 Million | -17.91 Million | -29.74 Million | -66.89 Million | -70.48 Million |
| Depreciation & Amortization | 1.23 Million | 998 Thousand | 1.16 Million | 706 Thousand | 683 Thousand | 594 Thousand |
| Deferred income taxes | -10.57 Million | - | 287 Thousand | - | - | - |
| Stock-based compensation | 8.8 Million | 12.38 Million | 9.48 Million | 7.29 Million | 9.11 Million | 7.7 Million |
| Change in working capital | 9.51 Million | -29.04 Million | 9.71 Million | -30.32 Million | 16.65 Million | 4.12 Million |
| Other non-cash items | 10.36 Million | 481 Thousand | 3.13 Million | -122 Thousand | -1.07 Million | -766 Thousand |
| Investing Cash Flow | -4.29 Million | 72.77 Million | -80.03 Million | 47.46 Million | -23.65 Million | 24.96 Million |
| Investments in PPE | -15 Million | -450 Thousand | -627 Thousand | -1.26 Million | -1.45 Million | -1.1 Million |
| Acquisitions | 259 Thousand | 893 Thousand | 627 Thousand | 1.26 Million | 1.45 Million | 1.1 Million |
| Investment purchases | -31.2 Million | -28.89 Million | -141.45 Million | -81.7 Million | -145.32 Million | -77.99 Million |
| Sales/Maturities of investments | 41.65 Million | 101.22 Million | 62.05 Million | 130.43 Million | 123.12 Million | 104.06 Million |
| Other Investing Activities | -4.29 Million | 73.22 Million | -627 Thousand | -1.26 Million | -1.45 Million | -1.1 Million |
| Financing Cash Flow | 18.36 Million | 6.55 Million | 62.67 Million | 12.57 Million | 11.36 Million | 71.89 Million |
| Debt repayment | -17.31 Million | -4.42 Million | -57.9 Million | -9.97 Million | -9.78 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.04 Million | 2.12 Million | 4.77 Million | 2.59 Million | 1.57 Million | 71.89 Million |
| Other Financing Activities | 34.63 Million | 8.85 Million | 62.67 Million | 19.95 Million | 19.57 Million | 71.89 Million |
| Accounts receivables | 9.77 Million | -24.84 Million | 501 Thousand | -5.86 Million | -6.03 Million | -4.07 Million |
| Accounts payables | -366 Thousand | 3.78 Million | 41 Thousand | -331 Thousand | -2.23 Million | 3.75 Million |
| Inventory | 1.17 Million | -2.37 Million | -4.87 Million | -126 Thousand | -366 Thousand | -839 Thousand |
| Other working capital | -1.05 Million | -5.61 Million | 14.05 Million | -24 Million | 25.29 Million | 5.28 Million |
| Cash at beginning of period | 24.45 Million | 18.89 Million | 30.37 Million | 22.52 Million | 76.32 Million | 38.29 Million |
| Cash at end of period | 32.78 Million | 24.45 Million | 18.89 Million | 30.37 Million | 22.52 Million | 76.32 Million |
| Capital Expenditure | -15 Million | -450 Thousand | -627 Thousand | -1.26 Million | -1.45 Million | -1.1 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 8.32 Million | 5.56 Million | -11.48 Million | 7.85 Million | -53.8 Million | 38.03 Million |
| Free Cash Flow | -20.74 Million | -74.2 Million | 5.25 Million | -53.44 Million | -42.96 Million | -59.93 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.03 Million | -8.24 Million | 737 Thousand | -25.09 Million | -5.69 Million | -6.6 Million |
| Depreciation & Amortization | 613 Thousand | 400 Thousand | 293 Thousand | 1.23 Million | 292 Thousand | 296 Thousand |
| Deferred income taxes | - | - | -3.99 Million | -10.57 Million | 1.81 Million | 2.17 Million |
| Stock-based compensation | 2.52 Million | 5.13 Million | 1.93 Million | 8.8 Million | 1.94 Million | 2.17 Million |
| Change in working capital | -1.65 Million | -2.09 Million | -8.83 Million | 9.51 Million | 2.22 Million | 10.05 Million |
| Other non-cash items | 10.32 Million | 2.86 Million | -370 Thousand | 10.36 Million | -1.94 Million | -2.17 Million |
| Investing Cash Flow | 10.92 Million | 313 Thousand | -6.87 Million | -4.29 Million | -1.17 Million | 2.97 Million |
| Investments in PPE | -222 Thousand | -138 Thousand | -110 Thousand | -15 Million | -22 Thousand | - |
| Acquisitions | - | - | 110 Thousand | 259 Thousand | 22 Thousand | - |
| Investment purchases | -7.54 Million | -7.79 Million | -12.98 Million | -31.2 Million | -9.44 Million | -8.78 Million |
| Sales/Maturities of investments | 18.7 Million | 8.25 Million | 6 Million | 41.65 Million | 8.25 Million | 11.75 Million |
| Other Investing Activities | 10.92 Million | 313 Thousand | 110 Thousand | -4.29 Million | 22 Thousand | 2.97 Million |
| Financing Cash Flow | -752 Thousand | -2.51 Million | 486 Thousand | 18.36 Million | -869 Thousand | -373 Thousand |
| Debt repayment | -1 Million | -2.6 Million | -20.92 Million | -17.31 Million | -878 Thousand | -926 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 252 Thousand | 89 Thousand | 486 Thousand | 1.04 Million | 9000.00 | 553 Thousand |
| Other Financing Activities | -1 Million | -2.6 Million | 486 Thousand | 34.63 Million | -878 Thousand | -926 Thousand |
| Accounts receivables | -1.39 Million | 3.03 Million | -7 Million | 9.77 Million | -2.72 Million | 8.54 Million |
| Accounts payables | -3.14 Million | 2.13 Million | -857 Thousand | -366 Thousand | 2.75 Million | -1.05 Million |
| Inventory | -2.19 Million | -2.31 Million | 2.53 Million | 1.17 Million | 281 Thousand | 309 Thousand |
| Other working capital | 5.08 Million | -4.95 Million | -3.5 Million | -1.05 Million | 1.91 Million | 2.25 Million |
| Cash at beginning of period | 25.57 Million | 32.78 Million | 45.41 Million | 24.45 Million | 48.81 Million | 40.28 Million |
| Cash at end of period | 36.05 Million | 25.57 Million | 32.78 Million | 32.78 Million | 45.41 Million | 48.81 Million |
| Capital Expenditure | -222 Thousand | -138 Thousand | -110 Thousand | -15 Million | -22 Thousand | - |
| Effect of forex changes on cash | - | - | 1.01 Million | - | 5.34 Million | -6.35 Million |
| Net cash flow / Change in cash | 10.47 Million | -7.21 Million | -12.62 Million | 8.32 Million | -3.39 Million | 8.52 Million |
| Free Cash Flow | 80 Thousand | -5.15 Million | -6.35 Million | -20.74 Million | -1.38 Million | 5.93 Million |
5401
FATBW
BHVN
AXL
AER
LFCOF